Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy

Purpose Genetically encoded reporters can assist in visualizing biological processes in live organisms and have been proposed for longitudinal and noninvasive tracking of therapeutic cells in deep tissue. Cells can be labeled in situ or ex vivo and followed in live subjects over time. Nevertheless,...

Full description

Saved in:
Bibliographic Details
Published inMagnetic resonance in medicine Vol. 79; no. 2; pp. 1010 - 1019
Main Authors Bar‐Shir, Amnon, Alon, Lina, Korrer, Michael J., Lim, Hong Seo, Yadav, Nirbhay N., Kato, Yoshinori, Pathak, Arvind P., Bulte, Jeff W.M., Gilad, Assaf A.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.02.2018
Subjects
MRI
MRI
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose Genetically encoded reporters can assist in visualizing biological processes in live organisms and have been proposed for longitudinal and noninvasive tracking of therapeutic cells in deep tissue. Cells can be labeled in situ or ex vivo and followed in live subjects over time. Nevertheless, a major challenge for reporter systems is to identify the cell population that actually expresses an active reporter. Methods We have used a nucleoside analog, pyrrolo‐2′‐deoxycytidine, as an imaging probe for the putative reporter gene, Drosophila melanogaster 2′‐deoxynucleoside kinase. Bioengineered cells were imaged in vivo in animal models of brain tumor and immunotherapy using chemical exchange saturation transfer MRI. The number of transduced cells was quantified by flow cytometry based on the optical properties of the probe. Results We performed a comparative analysis of six different cell lines and demonstrate utility in a mouse model of immunotherapy. The proposed technology can be used to quantify the number of labeled cells in a given region, and moreover is sensitive enough to detect less than 10,000 cells. Conclusion This unique technology that enables efficient selection of labeled cells followed by in vivo monitoring with both optical and MRI. Magn Reson Med 79:1010–1019, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
Bibliography:These authors contributed equally to this work.
Supported by grants from the Maryland Stem Cell Research Foundation MSCRFII‐0042, MSCRFF‐0103‐00, and NIH grant NS079288.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Current affiliation: The Weizmann Institute of Science, Rehovot, Israel.
ISSN:0740-3194
1522-2594
1522-2594
DOI:10.1002/mrm.26708